Teva Metoprolol Succinate 200 mg Recall Affects 19,056 Bottles Nationwide (2026)
Teva Pharmaceuticals recalled 19,056 bottles of Metoprolol Succinate Extended-Release Tablets, 200 mg, sold nationwide. The recall cites failed dissolution specifications, which could affect how the drug releases in the body. Patients should stop using the product and contact Teva or their healthcare provider for guidance.
Product Details
- NDC: 45963-678-11\n- Product: Metoprolol Succinate Extended-Release Tablets, 200 mg\n- Bottles per package: 100 tablets\n- Quantity recalled: 19,056 bottles\n- Lot numbers: 0686H251, 0687H251, 10688H251\n- Expiration: 02/2027\n- Brand: METOPROLOL SUCCINATE\n- Manufacturer: Teva Pharmaceuticals USA, Parsippany, NJ\n- Sold nationwide\n- Recall date: 2026-01-29
The Hazard
The product failed dissolution specifications. If tablets do not dissolve properly, the drug may not release the intended amount of metoprolol, potentially reducing effectiveness or causing unexpected blood pressure changes.
The Hazard
The product failed dissolution specifications. If tablets do not dissolve properly, the drug may not release the intended amount of metoprolol, potentially reducing effectiveness or causing unexpected blood pressure changes.